Document and Entity Information |
Sep. 19, 2023 |
|---|---|
| Cover [Abstract] | |
| Amendment Flag | true |
| Entity Central Index Key | 0001419041 |
| Document Type | 8-K/A |
| Document Period End Date | Sep. 19, 2023 |
| Entity Registrant Name | FORTE BIOSCIENCES, INC. |
| Entity Incorporation State Country Code | DE |
| Entity File Number | 001-38052 |
| Entity Tax Identification Number | 26-1243872 |
| Entity Address, Address Line One | 3060 Pegasus Park Dr. |
| Entity Address, Address Line Two | Building 6 |
| Entity Address, City or Town | Dallas |
| Entity Address, State or Province | TX |
| Entity Address, Postal Zip Code | 75247 |
| City Area Code | (310) |
| Local Phone Number | 618-6994 |
| Written Communications | false |
| Soliciting Material | false |
| Pre Commencement Tender Offer | false |
| Pre Commencement Issuer Tender Offer | false |
| Security 12b Title | Common Stock, $0.001 par value |
| Trading Symbol | FBRX |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | false |
| Amendment Description | This Current Report on Form 8-K/A is being filed by Forte Biosciences, Inc. (the “Company”) as an amendment (the “Amendment”) to the Current Report on Form 8-K filed by the Company with the U.S. Securities and Exchange Commission (the “SEC”) on September 20, 2023 (the “Original 8-K”) to report the preliminary voting results of the Company’s 2023 annual meeting of stockholders (the “Annual Meeting”) held on September 19, 2023. This Amendment is being filed to report the final voting results as certified by the independent inspector of elections for the Annual Meeting. |